Cipla
Jayant Pol has extensive experience in quality operations and assurance within the pharmaceutical industry. Currently serving as Associate Director of Quality Operations and Cluster Head of Quality Assurance at Cipla since February 2021, Jayant previously held the position of Regional Quality Compliance Manager at Teva Pharmaceuticals, overseeing compliance for Asia Pacific, Israel, Ireland, and Growth Markets. Earlier roles include responsibilities as Assistant Manager at Actavis Pharma Pvt. Ltd., Sr. Executive at Sandoz India Pvt Ltd, and Sr. Executive in Lab QA at Watson Pharma Pvt Ltd. Jayant began the career as an Executive at Lupin Limited and an Officer in QC at Cure Medicines India Private Limited. Educational qualifications include an Advanced Diploma in Technical and Analytical Chemistry from Bharati Vidyapeeth.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.